Pharmafile Logo

News and Press Releases

KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF

Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression, following a recent £90m Series A financing 12 September 2024:...

Category: BioManufacturing, Biotechnology
Posted: September 12, 2024

Kadans Science Partner
info@kadans.com
Rijksweg 5 5076 PB Haaren The Netherlands

Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge

New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys Latest ground-up development in Cambridge delivered by Kadans Science...

Category: Logistics, Other
Posted: July 24, 2024

Kadans Science Partner
info@kadans.com
Rijksweg 5 5076 PB Haaren The Netherlands

Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors...

Category: BioManufacturing, Clinical Trials, Other
Posted: July 8, 2024

Myricx
info@myricxbio.com
Myricx Bio Gridiron Building, 1 Pancras Square, King’s Cross, London, N1C 4AG

MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid...

Category: Biotechnology, Manufacturing and Packing, Pharmaceutical
Posted: June 6, 2024

Kadans Science Partner
info@kadans.com
Rijksweg 5 5076 PB Haaren The Netherlands